UniProt ID | GOPC_HUMAN | |
---|---|---|
UniProt AC | Q9HD26 | |
Protein Name | Golgi-associated PDZ and coiled-coil motif-containing protein | |
Gene Name | GOPC | |
Organism | Homo sapiens (Human). | |
Sequence Length | 462 | |
Subcellular Localization |
Cytoplasm. Golgi apparatus membrane Peripheral membrane protein. Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein. Cell junction, synapse. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Cell projection |
|
Protein Description | Plays a role in intracellular protein trafficking and degradation. May regulate CFTR chloride currents and acid-induced ASIC3 currents by modulating cell surface expression of both channels. May also regulate the intracellular trafficking of the ADR1B receptor. May play a role in autophagy. Overexpression results in CFTR intracellular retention and degradation in the lysosomes.. | |
Protein Sequence | MSAGGPCPAAAGGGPGGASCSVGAPGGVSMFRWLEVLEKEFDKAFVDVDLLLGEIDPDQADITYEGRQKMTSLSSCFAQLCHKAQSVSQINHKLEAQLVDLKSELTETQAEKVVLEKEVHDQLLQLHSIQLQLHAKTGQSADSGTIKAKLSGPSVEELERELEANKKEKMKEAQLEAEVKLLRKENEALRRHIAVLQAEVYGARLAAKYLDKELAGRVQQIQLLGRDMKGPAHDKLWNQLEAEIHLHRHKTVIRACRGRNDLKRPMQAPPGHDQDSLKKSQGVGPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYVAPEVDSDDENVEYEDESGHRYRLYLDELEGGGNPGASCKDTSGEIKVLQGFNKKAVTDTHENGDLGTASETPLDDGASKLDDLHTLYHKKSY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSAGGPCPA ------CCCCCCCCC | 35.30 | 19413330 | |
2 | Phosphorylation | ------MSAGGPCPA ------CCCCCCCCC | 35.30 | 19413330 | |
19 | Phosphorylation | GGGPGGASCSVGAPG CCCCCCCCCCCCCCC | 15.36 | 28348404 | |
21 | Phosphorylation | GPGGASCSVGAPGGV CCCCCCCCCCCCCCC | 22.53 | 28348404 | |
39 | Ubiquitination | RWLEVLEKEFDKAFV HHHHHHHHHHHHHHC | 60.56 | 29967540 | |
86 | Phosphorylation | QLCHKAQSVSQINHK HHHHHHHCHHHHCHH | 28.70 | 25849741 | |
88 | Phosphorylation | CHKAQSVSQINHKLE HHHHHCHHHHCHHHH | 30.50 | 30622161 | |
93 | Ubiquitination | SVSQINHKLEAQLVD CHHHHCHHHHHHHCH | 43.46 | 32015554 | |
93 | Malonylation | SVSQINHKLEAQLVD CHHHHCHHHHHHHCH | 43.46 | 26320211 | |
93 | Acetylation | SVSQINHKLEAQLVD CHHHHCHHHHHHHCH | 43.46 | 20167786 | |
102 | Sumoylation | EAQLVDLKSELTETQ HHHHCHHHHHCCHHH | 37.10 | - | |
102 (in isoform 3) | Ubiquitination | - | 37.10 | 21906983 | |
102 (in isoform 2) | Ubiquitination | - | 37.10 | 21906983 | |
102 | Sumoylation | EAQLVDLKSELTETQ HHHHCHHHHHCCHHH | 37.10 | - | |
102 (in isoform 1) | Ubiquitination | - | 37.10 | 21906983 | |
102 | Ubiquitination | EAQLVDLKSELTETQ HHHHCHHHHHCCHHH | 37.10 | 21906983 | |
103 | Phosphorylation | AQLVDLKSELTETQA HHHCHHHHHCCHHHH | 45.17 | 26074081 | |
106 | Phosphorylation | VDLKSELTETQAEKV CHHHHHCCHHHHHHH | 32.70 | 26074081 | |
108 | Phosphorylation | LKSELTETQAEKVVL HHHHCCHHHHHHHHH | 28.04 | 26074081 | |
112 | 2-Hydroxyisobutyrylation | LTETQAEKVVLEKEV CCHHHHHHHHHCHHH | 40.43 | - | |
112 | Ubiquitination | LTETQAEKVVLEKEV CCHHHHHHHHHCHHH | 40.43 | 29967540 | |
136 | Ubiquitination | IQLQLHAKTGQSADS EEEEEECCCCCCCCC | 42.30 | 29967540 | |
143 | Phosphorylation | KTGQSADSGTIKAKL CCCCCCCCCEEEEEC | 37.24 | 27251275 | |
145 | Phosphorylation | GQSADSGTIKAKLSG CCCCCCCEEEEECCC | 24.21 | 28857561 | |
145 (in isoform 2) | Phosphorylation | - | 24.21 | - | |
147 | Ubiquitination | SADSGTIKAKLSGPS CCCCCEEEEECCCCC | 39.03 | 27667366 | |
147 (in isoform 1) | Ubiquitination | - | 39.03 | 21906983 | |
147 (in isoform 2) | Ubiquitination | - | 39.03 | 21906983 | |
147 (in isoform 3) | Ubiquitination | - | 39.03 | 21906983 | |
149 | Ubiquitination | DSGTIKAKLSGPSVE CCCEEEEECCCCCHH | 37.88 | 30230243 | |
151 | Phosphorylation | GTIKAKLSGPSVEEL CEEEEECCCCCHHHH | 48.20 | 26657352 | |
154 | Phosphorylation | KAKLSGPSVEELERE EEECCCCCHHHHHHH | 45.76 | 22985185 | |
170 | Sulfoxidation | EANKKEKMKEAQLEA HHHHHHHHHHHHHHH | 5.07 | 21406390 | |
171 | Ubiquitination | ANKKEKMKEAQLEAE HHHHHHHHHHHHHHH | 62.05 | - | |
172 | Ubiquitination | NKKEKMKEAQLEAEV HHHHHHHHHHHHHHH | 37.84 | 29967540 | |
180 | Ubiquitination | AQLEAEVKLLRKENE HHHHHHHHHHHHHHH | 33.05 | 29967540 | |
200 | Ubiquitination | IAVLQAEVYGARLAA HHHHHHHHHHHHHHH | 6.31 | 29967540 | |
201 | Phosphorylation | AVLQAEVYGARLAAK HHHHHHHHHHHHHHH | 9.14 | 18083107 | |
204 | Ubiquitination | QAEVYGARLAAKYLD HHHHHHHHHHHHHHC | 22.09 | 29967540 | |
208 | Ubiquitination | YGARLAAKYLDKELA HHHHHHHHHHCHHHH | 40.51 | 29967540 | |
209 | Phosphorylation | GARLAAKYLDKELAG HHHHHHHHHCHHHHH | 18.53 | 18083107 | |
212 | Ubiquitination | LAAKYLDKELAGRVQ HHHHHHCHHHHHHHH | 52.62 | 29967540 | |
270 | Ubiquitination | KRPMQAPPGHDQDSL CCCCCCCCCCCHHHH | 56.62 | 29967540 | |
271 | Ubiquitination | RPMQAPPGHDQDSLK CCCCCCCCCCHHHHH | 35.62 | 29967540 | |
276 | Phosphorylation | PPGHDQDSLKKSQGV CCCCCHHHHHHHCCC | 36.13 | 28985074 | |
278 | Ubiquitination | GHDQDSLKKSQGVGP CCCHHHHHHHCCCCC | 55.09 | 29967540 | |
279 | Ubiquitination | HDQDSLKKSQGVGPI CCHHHHHHHCCCCCC | 53.99 | 29967540 | |
280 | Phosphorylation | DQDSLKKSQGVGPIR CHHHHHHHCCCCCCC | 30.49 | 29743597 | |
302 | Phosphorylation | DHEGLGISITGGKEH CCCCCEEEECCCHHH | 16.58 | 28348404 | |
342 | Ubiquitination | AILAVNGVNLRDTKH EEEEECCCCCCCCCC | 5.27 | 33845483 | |
350 | Ubiquitination | NLRDTKHKEAVTILS CCCCCCCHHHHHHHH | 49.26 | 33845483 | |
369 | Phosphorylation | EIEFEVVYVAPEVDS EEEEEEEEEECCCCC | 8.96 | 26657352 | |
376 | Phosphorylation | YVAPEVDSDDENVEY EEECCCCCCCCCCEE | 52.73 | 27362937 | |
383 | Phosphorylation | SDDENVEYEDESGHR CCCCCCEEECCCCCE | 25.13 | 26074081 | |
387 | Phosphorylation | NVEYEDESGHRYRLY CCEEECCCCCEEEEE | 52.82 | 26074081 | |
391 | Phosphorylation | EDESGHRYRLYLDEL ECCCCCEEEEEEEEC | 10.17 | 26074081 | |
394 | Phosphorylation | SGHRYRLYLDELEGG CCCEEEEEEEECCCC | 11.78 | 28796482 | |
401 | Ubiquitination | YLDELEGGGNPGASC EEEECCCCCCCCCCC | 24.27 | 29967540 | |
407 | Phosphorylation | GGGNPGASCKDTSGE CCCCCCCCCCCCCCC | 27.84 | 29507054 | |
408 | Ubiquitination | GGNPGASCKDTSGEI CCCCCCCCCCCCCCE | 4.60 | 32015554 | |
409 | Ubiquitination | GNPGASCKDTSGEIK CCCCCCCCCCCCCEE | 62.64 | 29967540 | |
411 | Phosphorylation | PGASCKDTSGEIKVL CCCCCCCCCCCEEEE | 24.91 | 21712546 | |
412 | Phosphorylation | GASCKDTSGEIKVLQ CCCCCCCCCCEEEEE | 44.56 | 29214152 | |
415 | Ubiquitination | CKDTSGEIKVLQGFN CCCCCCCEEEEECCC | 4.22 | 29967540 | |
416 | Sumoylation | KDTSGEIKVLQGFNK CCCCCCEEEEECCCC | 32.37 | - | |
416 | Ubiquitination | KDTSGEIKVLQGFNK CCCCCCEEEEECCCC | 32.37 | 32015554 | |
416 | Sumoylation | KDTSGEIKVLQGFNK CCCCCCEEEEECCCC | 32.37 | - | |
423 | 2-Hydroxyisobutyrylation | KVLQGFNKKAVTDTH EEEECCCCCCCCCCC | 39.59 | - | |
423 | Ubiquitination | KVLQGFNKKAVTDTH EEEECCCCCCCCCCC | 39.59 | 29967540 | |
437 | Phosphorylation | HENGDLGTASETPLD CCCCCCCCCCCCCCC | 34.02 | 26657352 | |
439 | Phosphorylation | NGDLGTASETPLDDG CCCCCCCCCCCCCCC | 41.67 | 25159151 | |
441 | Phosphorylation | DLGTASETPLDDGAS CCCCCCCCCCCCCCC | 27.02 | 28985074 | |
451 | Ubiquitination | DDGASKLDDLHTLYH CCCCCCHHHHHHHHC | 61.23 | 29967540 | |
455 | Phosphorylation | SKLDDLHTLYHKKSY CCHHHHHHHHCCCCC | 35.99 | 29978859 | |
457 | Phosphorylation | LDDLHTLYHKKSY-- HHHHHHHHCCCCC-- | 16.85 | 14729942 | |
459 | Ubiquitination | DLHTLYHKKSY---- HHHHHHCCCCC---- | 29.83 | 29967540 | |
461 | Phosphorylation | HTLYHKKSY------ HHHHCCCCC------ | 40.66 | 24719451 | |
462 | Phosphorylation | TLYHKKSY------- HHHCCCCC------- | 31.30 | 14729942 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GOPC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GOPC_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-457 AND TYR-462, ANDMASS SPECTROMETRY. |